The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion.
about
S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancerPhosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancerNVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells.Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patientsGenetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells.Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.Personalized therapy for urothelial cancer: review of the clinical evidence.Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinomaEmerging drugs for targeted therapy of bladder cancer.Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignanciesKaempferol promotes apoptosis in human bladder cancer cells by inducing the tumor suppressor, PTEN.B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway.Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway.Neoadjuvant chemotherapy for invasive bladder cancer.Novel molecular targets for the therapy of urothelial carcinoma.Phosphatidylinositol 3'-kinase, mTOR, and glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cellsAkt activation correlates with the tumor aggressiveness in Tunisian patients with bladder cancer.Afatinib inhibits proliferation and invasion and promotes apoptosis of the T24 bladder cancer cell line.IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.Effect of sirolimus on urinary bladder cancer T24 cell line.The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt.Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray.PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs.PI3K/AKT pathway activation in bladder carcinogenesis.Desethylamiodarone-A metabolite of amiodarone-Induces apoptosis on T24 human bladder cancer cells via multiple pathways.Curcumin Induces Apoptosis in EJ Bladder Cancer Cells via Modulating C-Myc and PI3K/Akt Signaling Pathway.Urolithins impair cell proliferation, arrest the cell cycle and induce apoptosis in UMUC3 bladder cancer cells.A phase II trial of temsirolimus in second-line metastatic urothelial cancer.Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway.Clinical value of PTEN in patients with superficial bladder cancer.
P2860
Q28477972-45C77A41-2FFA-4A33-B082-91A7CFE26991Q33554443-247321AD-4763-42F5-A8E7-595A0DACFAD0Q34000632-7C5FF32C-8430-4D56-BE1F-064DEF0D9C3FQ34042341-727C1600-05BA-42F3-BAA8-553CEEA5B498Q34345248-EDAED25C-C776-4077-93E8-338FF23CC57BQ34743802-51BE5FCF-3B4B-48F5-9405-4619124BDE1AQ35841848-C0152423-6587-4003-8CF3-F9D88525665BQ36062762-66574417-736C-48DA-9D5D-C39B3B92D523Q36144821-B707F0A0-14C5-4E69-AFC7-523BA4906D3EQ36341182-69BAFBA6-54F9-43D1-A7C7-5438A91DE68FQ36598752-0731CC38-4409-4D4E-B48D-F970076C9610Q36820882-E14652CC-13FD-475B-95EF-257A81DAD44DQ36823682-3553FD69-4BCC-45C6-9D5A-30476EDD1019Q36944022-BF73F752-BD2A-4E8A-B846-B0F3CCACEA9EQ37195644-7E1BD570-0CF5-4426-BD94-C112BE34CC3EQ37375285-A637EEA4-A82F-4FF2-A93A-A2A1C10130ABQ37738088-B1DDA725-0068-40B6-8C64-0C9167F206FCQ37775890-0A9BBD6D-B405-404C-A0E5-DF26E391587CQ37982318-501C238C-6FEE-4A4C-A407-C523A272829BQ38003195-145CF964-E935-45B2-8BCE-F36A8B16C908Q38427265-3E88D16A-186C-4604-A511-92C7FD09736AQ38809335-FFF9FD25-9669-4C0D-8B87-9FAF5380BEA3Q38857343-00E3F9EE-BC74-462A-842B-62404D9ADC47Q39173839-2BBAD915-74C6-43B1-8E4E-1685E5C456E8Q39622272-725161D7-2BDF-46D3-B501-0DF008279636Q39667883-E15AE451-9531-4E32-8C22-5C00F6E772AEQ39898000-63000117-2CFC-401A-B753-F00348124E69Q40393538-CF2D6A43-4E02-474B-8380-6F6451DA2806Q40776023-42EED266-1BE1-4540-B78E-06B451532761Q42089905-DB903E51-26CA-4441-A6F3-039450898E35Q42798110-39ABA3E2-A231-4315-B439-4980863FE854Q46976450-444A2B8B-6C73-4C52-BAB0-E07120350856Q47134365-583F3BC3-6047-4F0C-A329-71159C089CFEQ47147815-0F99CE93-6030-4D69-A9C5-038320CF84E8Q48253399-35626BCD-F61B-4DB7-8AA2-971CA2C9BD25Q48463573-774AEBDD-6FBB-4E1B-98F9-3269E2717FE9Q48839946-40E624F9-2540-44F1-9EAA-79156C0B58C8Q51209998-5138F0F0-76F6-4310-85D1-EDF293305187Q52719999-D6204568-2C91-4D6A-B520-37B5E102E4BCQ53540396-497E04CA-3049-4DC0-A0B1-B66BCA9215C1
P2860
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion.
@en
type
label
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion.
@en
prefLabel
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion.
@en
P2093
P2860
P1433
P1476
The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion.
@en
P2093
P2860
P304
P356
10.1111/J.1464-410X.2004.04574.X
P577
2004-01-01T00:00:00Z